245 filings
Page 9 of 13
424B3
yao0r0igpmik8u3qmnri
22 Aug 22
Prospectus supplement
5:13pm
8-K
4ncvplh5x4
22 Aug 22
Results of Operations and Financial Condition
5:08pm
8-K
irh27
16 Aug 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:01pm
NT 10-Q
uh4mct4ba2hw0d
15 Aug 22
Notice of late quarterly filing
5:59pm
424B3
gji4dvglufh5vi
12 Aug 22
Prospectus supplement
5:30pm
8-K
h8eubl689
12 Aug 22
Entry into a Material Definitive Agreement
5:04pm
424B3
qyvicb21jpxlgv hlh
2 Aug 22
Prospectus supplement
9:35am
8-K
gq5zypyp2
2 Aug 22
Allarity Therapeutics Refocuses Oncology Pipeline Strategy Towards Combination Therapies
9:33am
424B3
6jjcg15qkp84gplta3p
11 Jul 22
Prospectus supplement
5:16pm
8-K
4d5yyi3k0w
11 Jul 22
Departure of Directors or Certain Officers
4:05pm
424B3
ebubws8oq nc
30 Jun 22
Prospectus supplement
6:34am
8-K
25mxbq1b eys7
29 Jun 22
Allarity Therapeutics Announces Executive Leadership Transition
7:44pm
8-K
m5dv1ar
10 Jun 22
Entry into a Material Definitive Agreement
4:01pm
424B3
mspjfa0gsk3ctd
7 Jun 22
Prospectus supplement
5:26pm
EFFECT
uglj8
7 Jun 22
Notice of effectiveness
12:15am
POS AM
0aunxv038bvq13j
2 Jun 22
Prospectus update (post-effective amendment)
7:58pm
8-K
qcxbax
27 May 22
Allarity Therapeutics Reports First Quarter 2022 Financial Results
5:29pm
8-K
ib1le kvcbdfqt
27 May 22
Regulation FD Disclosure
6:01am
8-K/A
dvhrv d9j
19 May 22
Correction Notice to Press Release Announcing Financial Results For the Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
6:05am